These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 26002423)

  • 41. [Management of arterial hypertension in adults: 2013 guidelines of the French Society of Arterial Hypertension].
    Blacher J; Halimi JM; Hanon O; Mourad JJ; Pathak A; Schnebert B; Girerd X;
    Ann Cardiol Angeiol (Paris); 2013 Jun; 62(3):132-8. PubMed ID: 23743000
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prescribing patterns in hypertension: the emerging role of fixed-dose combinations for attaining BP goals in hypertensive patients.
    Neutel JM
    Curr Med Res Opin; 2008 Aug; 24(8):2389-401. PubMed ID: 18616863
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An economic evaluation of the 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of mild-to-moderate hypertension in Greece.
    Stafilas PC; Sarafidis PA; Lasaridis AN; Aletras VH; Niakas DA
    Am J Hypertens; 2005 Sep; 18(9 Pt 1):1233-40; discussion 1241-2. PubMed ID: 16182115
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical experience in treating hypertension with fixed-dose combination therapy: angiotensin II receptor blocker losartan plus hydrochlorothiazide.
    Abe M; Okada K; Matsumoto K
    Expert Opin Drug Metab Toxicol; 2009 Oct; 5(10):1285-303. PubMed ID: 19761411
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Compliance, safety, and effectiveness of fixed-dose combinations of antihypertensive agents: a meta-analysis.
    Gupta AK; Arshad S; Poulter NR
    Hypertension; 2010 Feb; 55(2):399-407. PubMed ID: 20026768
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [European guidelines for the management of arterial hypertension 2018-what has changed?].
    Jung S; Schmieder RE
    Internist (Berl); 2019 Feb; 60(2):202-208. PubMed ID: 30649580
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Combination therapy in hypertension: an Asia-Pacific consensus viewpoint.
    Abdul Rahman AR; Reyes EB; Sritara P; Pancholia A; Van Phuoc D; Tomlinson B
    Curr Med Res Opin; 2015 May; 31(5):865-74. PubMed ID: 25707364
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hypertension control and antihypertensive therapy in patients with chronic kidney disease.
    Unni S; White K; Goodman M; Ye X; Mavros P; Bash LD; Brixner D
    Am J Hypertens; 2015 Jun; 28(6):814-22. PubMed ID: 25421796
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Olmesartan/amlodipine: blood pressure lowering and beyond in special populations.
    Erdine S
    Ther Adv Cardiovasc Dis; 2012 Feb; 6(1):31-44. PubMed ID: 22222315
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A comparison of the effects of fixed dose vs. single-agent combinations on 24-h blood pressure variability.
    Ulusoy S; Ozkan G; Konca C; Kaynar K
    Hypertens Res; 2012 Nov; 35(11):1111-7. PubMed ID: 22786565
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Ramipril plus amlodipine and lisinopril plus amlodipine fixed dose combinations and patient's adherence].
    Simonyi G; Ferenci T
    Orv Hetil; 2016 Jan; 157(1):30-4. PubMed ID: 26708684
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Safety and effectiveness of a fixed-dose combination of olmesartan, amlodipine, and hydrochlorothiazide in clinical practice.
    Bramlage P; Fronk EM; Wolf WP; Smolnik R; Sutton G; Schmieder RE
    Vasc Health Risk Manag; 2015; 11():1-8. PubMed ID: 25565857
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Valsartan-amlodipine-hydrochlorothiazide: the definitive fixed combination?
    Barrios V; Escobar C
    Expert Rev Cardiovasc Ther; 2010 Nov; 8(11):1609-18. PubMed ID: 21090936
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Long-term blood pressure control: what can we do?
    Neutel JM
    Postgrad Med; 2011 Jan; 123(1):88-93. PubMed ID: 21293088
    [TBL] [Abstract][Full Text] [Related]  

  • 55. How to implement the recommendations of the 2018 ESC/ESH Hypertension Guidelines in a given patient: a step by step approach.
    Coca A; Doménech M
    Eur Heart J Cardiovasc Pharmacother; 2019 Jul; 5(3):164-170. PubMed ID: 30851109
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Blood pressure control among stroke patients in Thailand--the i-STROKE study.
    Nidhinandana S; Ratanakorn D; Charnnarong N; Muengtaweepongsa S; Towanabut S;
    J Stroke Cerebrovasc Dis; 2014 Mar; 23(3):476-83. PubMed ID: 23800493
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Overcoming clinical inertia to achieve blood pressure goals: the role of fixed-dose combination therapy.
    Basile J; Neutel J
    Ther Adv Cardiovasc Dis; 2010 Apr; 4(2):119-27. PubMed ID: 20042448
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Population impact of the 2017 ACC/AHA guidelines compared with the 2013 ESH/ESC guidelines for hypertension management.
    Vaucher J; Marques-Vidal P; Waeber G; Vollenweider P
    Eur J Prev Cardiol; 2018 Jul; 25(10):1111-1113. PubMed ID: 29637794
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antihypertensive medication changes and blood pressure goal achievement in a managed care population.
    Engel-Nitz NM; Darkow T; Lau H
    J Hum Hypertens; 2010 Oct; 24(10):659-68. PubMed ID: 20107489
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Are fixed-dose combination antihypertensives suitable as first-line therapy?
    Kjeldsen SE; Messerli FH; Chiang CE; Meredith PA; Liu L
    Curr Med Res Opin; 2012 Oct; 28(10):1685-97. PubMed ID: 22978777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.